UK Markets closed

CNO Financial Group, Inc. (CNO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
24.52-0.71 (-2.81%)
As of 02:15PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close25.23
Bid24.50 x 1000
Ask24.55 x 800
Day's range24.38 - 25.75
52-week range21.06 - 27.89
Avg. volume863,900
Market cap3.024B
Beta (5Y monthly)1.35
PE ratio (TTM)7.58
EPS (TTM)3.24
Earnings date07 Feb 2022 - 11 Feb 2022
Forward dividend & yield0.52 (2.06%)
Ex-dividend date09 Dec 2021
1y target est28.20
  • Business Wire

    AM Best Upgrades Credit Ratings of CNO Financial Group, Inc. and Its Life/Health Subsidiaries

    OLDWICK, N.J., January 26, 2022--AM Best has upgraded the Financial Strength Rating to A (Excellent) from A- (Excellent) and the Long-Term Issuer Credit Rating to "a" (Excellent) from "a-" (Excellent) for the life/health subsidiaries of CNO Financial Group, Inc. (headquartered in Carmel, IN) [NYSE: CNO]. These subsidiaries are referred to collectively as CNO Financial Group (CNO). Concurrently, AM Best has upgraded the Long-Term ICR to "bbb" (Good) from "bbb-" (Good) and the Long-Term Issue Cred

  • Business Wire

    NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors

    ELMSFORD, N.Y., January 13, 2022--NanoVibronix Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced its board of directors has appointed Ms. Aurora (Rori) Cassirer and Ms. Maria (Lulu) Schroeder to serve as independent directors effective today.

  • Zacks

    Why Should You Add CNO Financial (CNO) to Your Portfolio?

    CNO Financial (CNO) holds prospects to benefit investors owing to its declining costs, technological investments, a solid portfolio and strategic measures.